EASL – The Digital International Liver Congress 2020

Published on 26/08/2020

August 27-29, 2020
Digital congress

ENYO Pharma was connected from the 27th to the 29th of August at the digital EASL International Liver Congress and present 2 posters.

“Characterization of EYP001 a novel, potent and selective FXR agonist in in vitro 3D human liver models”

“A novel small molecule modulating the mitochondrial NEET (CISD) proteins activity improves inflammation and fibrosis in a diet-induced model of non-alcoholic steatohepatitis”

Read next in 'Events'

• J.P. Morgan week and WuXi Global Forum 2025 in San Francisco
• J.P. Morgan week et WuXi Global Forum 2025 à San Francisco
• 4th Rare & Genetic Kidney Disease Drug Development Summit
• 4th Rare & Genetic Kidney Disease Drug Development Summit
• MOSAIC - Global NASH Trialist Forum 2024